Serum bactericidal effect on Pseudomonas aeruginosa isolates from cystic fibrosis patients. (Q36425886)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6792079%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

title

Serum bactericidal effect on Pseudomonas aeruginosa isolates from cystic fibrosis patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6792079%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

main subject

Pseudomonas aeruginosa

0 references

0 references

M J Thomassen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6792079%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

C A Demko

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6792079%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

language of work or name

English

0 references

publication date

1 August 1981

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6792079%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

published in

Infection and Immunity

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6792079%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6792079%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6792079%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

page(s)

512-518

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6792079%20AND%20SRC:MED&resulttype=core&format=json

Bacterial Infection in Cystic Fibrosis

19 October 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=350729

Influence of the alternate complement pathway in opsonization of several bacterial species

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=350729

Selective activation of classical and alternative pathways of human complement by "promptly serum-sensitive" and "delayed serum-sensitive" strains of Serratia marcescens

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=350729

Multiple Isolates of Pseudomonas aeruginosa with Differing Antimicrobial Susceptibility Patterns from Patients with Cystic Fibrosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=350729

Inhibitory effect of cystic fibrosis serum on pseudomonas phagocytosis by rabbit and human alveolar macrophages

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=350729

Complement-mediated phagocytosis of Pseudomonas aeruginosa

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=350729

Research in cystic fibrosis (third of three parts).

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=350729

Bacterial blocking activity of specific IgG in chronic Pseudomonas aeruginosa infection

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=350729

Pseudomonas aeruginosa infection in cystic fibrosis. Bactericidal effect of serum from normal individuals and patients with cystic fibrosis on P. aeruginosa strains from patients with cystic fibrosis or other diseases

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=350729

A factor in the serum of patients with persisting infection that inhibits the bactericidal activity of normal serum against the organism that is causing the infection

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=350729

Evaluation of a prophylactic and therapeutic program for patients with cystic fibrosis

28 June 2018

1 reference

12 December 2020

A report on sixty-five patients over 17 years of age

1 reference

12 December 2020

Human Immunity to Pseudomonas aeruginosa. I. In-Vitro Interaction of Bacteria, Polymorphonuclear Leukocytes, and Serum Factors

1 reference

12 December 2020

C3 shunt activation in human serum chelated with EGTA

1 reference

12 December 2020

Delayed hypersensitivity skin testing. I. Response rates in a hospitalized population

1 reference

12 December 2020

Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage

1 reference

12 December 2020

Pseudomonas: the compromised host

1 reference

12 December 2020

Immune complexes and humoral response to Pseudomonas aeruginosa in cystic fibrosis

1 reference

12 December 2020

Ultrastructure and function of alveolar macrophages from cystic fibrosis patients

1 reference

12 December 2020

THE IDENTIFICATION OF ATYPICAL STRAINS OF PSEUDOMONAS AERUGINOSA

1 reference

12 December 2020